Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
80 participants
INTERVENTIONAL
2018-06-27
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurocognitive Rehabilitation Using Virtual Reality
NCT04017091
Training Reward Responsiveness Through Virtual Reality
NCT07219875
The Development of a Virtual Reality Program to Improve Attention in Individuals With TBI
NCT03605017
Study to Improve Ambulation in Individuals With TBI Using Virtual Reality -Based Treadmill Training
NCT05130658
Virtual Reality Cognitive Training for Mild Cognitive Impairment
NCT06380894
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control in VR
Adults ages 18 to 35 who will be training in Virtual Reality.
Training in Virtual Reality
Action Video Game Based Training in Virtual Reality
Control Non-VR
Adults ages 18 to 35 who will be training on a computer screen.
Training on a computer screen
Action Video Game Based Training on a computer screen
College Athletes with TBI Group
Adults ages 18 to 35 with mild TBI who will be training in Virtual Reality
Training in Virtual Reality
Action Video Game Based Training in Virtual Reality
Older Adult Group
Older Adults over the age of 65 who will be training in Virtual Reality
Training in Virtual Reality
Action Video Game Based Training in Virtual Reality
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Training in Virtual Reality
Action Video Game Based Training in Virtual Reality
Training on a computer screen
Action Video Game Based Training on a computer screen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Is an adult over the age of 18.
* Has the capacity to give consent.
* Has normal or corrected to normal vision.
* Has adequate hearing.
* Is a non-action video game player.
* Is a non-VR game player. All subjects will be assigned to one of four groups: a Control Group training in VR, a Control Groups training on a 2D display, an Older Adult Group without dementia training in VR, and a College Athletes with mild TBI Group training in VR.
* Be between the ages of 18 and 35.
* Have no neurologic or vascular disorders/injuries.
* Be between the ages of 18 and 35.
* Be diagnosed with mild TBI (i.e., concussion) within the last two weeks.
* Be over the age of 65.
* Have no neurologic or vascular disorders/injuries.
Exclusion Criteria
• Is under the age of 18.
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NeuroTrainer
INDUSTRY
University of Rochester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Duje Tadin
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Duje Tadin, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Rochester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Rochester
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
70869
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.